Clinical Trials on Breast Carcinoma in New Zealand
Total 5776 results
-
PfizerCompleted
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterSamus Therapeutics, Inc.CompletedMetastatic Breast CancerUnited States
-
Alaunos TherapeuticsCompletedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; University of British Columbia; University of Pittsburgh and other collaboratorsCompletedBreast Surgery | Breast Cancer | Breast Augmentation | Breast Reconstruction | Breast ReductionUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareActive, not recruitingMetastatic HER2-Positive Breast CancerUnited States
-
Icahn School of Medicine at Mount SinaiTerminatedLocally Advanced Breast CancerUnited States
-
Weill Medical College of Cornell UniversityTerminatedNewly Diagnosed Breast CancerUnited States
-
NYU Langone HealthCompletedBreast CancerUnited States
-
ExelixisWithdrawnCancer | Breast Cancer | Non-small-cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal CancerNew Zealand, Australia, United Kingdom
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Columbia UniversityNational Cancer Institute (NCI); University of Wisconsin, Madison; National Institute...UnknownBreast Cancer RiskUnited States
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Indiana UniversityCompletedMetastatic Breast CancerUnited States
-
Relay Therapeutics, Inc.Active, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Unresectable Solid Tumor | PIK3CA MutationUnited States
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUnited States Department of DefenseActive, not recruitingBreast Cancer | Metastatic HER2-negative BreastUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Musculoskeletal ComplicationsUnited States
-
Weill Medical College of Cornell UniversityRecruiting
-
NYU Langone HealthCompleted
-
Memorial Sloan Kettering Cancer CenterPfizer; AmgenCompletedDose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityBreast Cancer | Adenocarcinoma of the BreastUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Invasive Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedMetastatic Breast CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast CarcinomaUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Invasive Adenocarcinoma of the BreastUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedInvasive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedHER2-Positive Early Stage Breast CancerUnited States
-
Roswell Park Cancer InstituteTerminatedObesity | Overweight | Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer SurvivorsUnited States
-
Volastra Therapeutics, Inc.RecruitingGastric Adenocarcinoma | Uterine Carcinosarcoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Head and Neck Squamous Cell Carcinoma | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Transitional Cell Carcinoma of Bladder | Colorectal Adenocarcinoma | Gastroesophageal Junction... and other conditionsUnited States
-
ETOP IBCSG Partners FoundationCompletedBreast CancerFrance, Switzerland, Australia, Peru, Italy, New Zealand, Slovenia, Belgium, Brazil, Denmark
-
Incyte Biosciences International SàrlCompletedCervical Cancer | Hepatocellular Carcinoma | Esophageal Cancer | Ovarian Cancer | Mesothelioma | Non-small Cell Lung Cancer (NSCLC) | Urothelial Carcinoma | Merkel Cell Carcinoma | Diffuse Large B-cell Lymphoma | Triple-negative Breast Cancer | Renal Cell Carcinoma (RCC) | Small Cell Lung Cancer (SCLC) | Squamous... and other conditionsUnited States
-
Stony Brook UniversityWithdrawnBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | DCISUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
State University of New York - Upstate Medical...Completed
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
Memorial Sloan Kettering Cancer CenterAmerican Cancer Society, Inc.Active, not recruiting
-
Yale UniversityFoundation MedicineCompleted
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Dartmouth-Hitchcock Medical CenterHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
GlaxoSmithKlineCompleted
-
University of VermontDartmouth-Hitchcock Medical Center; Maimonides Medical CenterUnknownBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.Active, not recruiting
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple -Negative Breast Cancer | Anatomic Stage IV Breast Cancer AJCCUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Neovii BiotechFresenius Biotech North AmericaTerminatedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterRecruitingInvasive Breast Cancer | Post-mastectomyUnited States